29 results
8-K
EX-1.1
BBIO
BridgeBio Pharma Inc
6 Mar 24
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
5:13pm
of counsel for the Underwriters in connection with such qualification and in connection with any Blue Sky survey; (iv) the filing fees incident … of any transfer agent or registrar; and (vii) all other costs and expenses incident to the performance of its obligations hereunder which are not otherwise
S-3ASR
BBIO
BridgeBio Pharma Inc
2 Nov 23
Automatic shelf registration
4:59pm
incident to the registration of the securities. We have agreed to indemnify each Selling Stockholder against certain losses, claims, damages
8-K
EX-10.1
BBIO
BridgeBio Pharma Inc
25 Sep 23
BridgeBio Pharma Announces $250 Million Private Placement Equity Financing
4:00pm
, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution
8-K
EX-10.2
mzow3cm
25 Sep 23
BridgeBio Pharma Announces $250 Million Private Placement Equity Financing
4:00pm
S-3ASR
pdzgzgi9h3
26 Jul 23
Automatic shelf registration
4:06pm
S-3ASR
EX-1.2
wun7qpla
4 May 23
Automatic shelf registration
4:55pm
8-K
EX-1.1
7lfhm9ggspcecujrfv
17 Feb 21
Entry into a Material Definitive Agreement
4:16pm
8-K
8lxmqa3nljk6t 265qnq
17 Feb 21
Entry into a Material Definitive Agreement
4:16pm
424B7
aln3xcymxt3
16 Feb 21
Prospectus with selling stockholder info
5:24pm
424B7
pr17q79i9vq2
11 Feb 21
Prospectus with selling stockholder info
5:15pm
8-K
EX-10.1
ts8nr9v258o23op
26 Jan 21
BridgeBio Pharma, Inc. Announces Proposed Offering of $400 Million Convertible Senior Notes
4:56pm
S-3ASR
03brs6n9lpi3 d1qh72x
28 Jul 20
Automatic shelf registration
4:45pm
S-3ASR
EX-1.2
79y3y9czpy1neq bjnr9
7 Jul 20
Automatic shelf registration
5:28pm
8-K
EX-10.1
ne7a2d5gqu
6 Mar 20
Entry into a Material Definitive Agreement
6:30am
8-K
EX-4.1
dvyym892 jez4zc8
3 Jul 19
Amendments to Articles of Incorporation or Bylaws
4:34pm